Easton Pharmaceuticals Inc (EAPH) 0.0430 $EAPH
Easton Pharmaceuticals Announces Mr. Kent Deuters as Chief Operations Officer and Special Advisor on the Company's Medical Marijuana Initiatives and Other Company Business Segments; Provides Further Updates on Its Medical Marijuana Program
Marketwire - Thu Apr 03, 11:05AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) announces the appointment of Mr. Kent A. Deuters to the position of Chief Operations Officer and Special Advisor.
CannabisFN Weekly: Cannabis Sector Gears Up for Canada's MMPR
ACCESSWIRE - Mon Mar 31, 8:01AM CDT
Whitefish, MT / March 31, 2014 / The Marijuana Indexâ?¢ moved lower over the past week due in large part to a 40% drop in shares of Cannavest Corp. (OTCBB: CANV) along with broader declines across the sector. Many traders appeared to be locking in profits after a volatile start to 2014 although cannabis stocks showed signs of recovery during Friday's session and long-term industry catalysts like regulatory reform remain very intact.
Easton Pharmaceuticals Announces Changes in Management and New Additions to Advisory Board; Appoints Dr. Albert PhD as New Marketing and Technology Officer and Appoints Tim Zorn, Current CEO of HempLifeToday.com to Advisory Board
Marketwire - Mon Mar 31, 7:03AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) -- announces it has appointed Carla Pepe as its new CEO and President, replacing John Adams who will assume the position of CFO. The company also announces the addition of Dr. Lilla Albert PhD to the advisory board, chief marketing officer, and Mr. Tim Zorn, current CEO of HempLifeToday.com (OTC: GLCO) to advisory board.
Easton Pharmaceuticals Announces Signing LOI for Joint Venture Towards Private Medical Marijuana Colorado Grower and Licenses; Provides Clarification on Its Canadian Medical Marijuana Initiatives
Marketwire - Fri Mar 28, 9:45AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces it has signed a letter of intent for the creation of a possible JV with another US company towards a Private Medical Marijuana company in the state of Colorado.
Easton Pharmaceuticals Announces Update to Its Cancer Drug Initiative: Majority Acquisition, Patent Strategy and Clinical Development Along With New Partnership Proposal Involving Medicinal Marijuana Drug Development
Marketwire - Tue Mar 25, 7:46AM CDT
Easton Pharmaceuticals, Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, announces it has entered into an agreement towards securing majority control of the cancer drug Xilive, pending certain conditions and a new partnership proposal towards medicinal marijuana.
Cannabis Science Finalizes $1 Million in New Financing
ACCESSWIRE - Wed Mar 19, 10:22AM CDT
A developer of cannabis-based pharmaceutical products Cannabis Science Inc. (NASDAQ OTC: CBIS) announced that it has finalized its $1,000,000 private placement and the funds have already been put into the bank.
Easton Pharmaceuticals Announces It Has Engaged Online Marketing and Branding Specialists to Support the Firm's Updated Products, Branding and Website Launch; Provides Update on Its Medical Marijuana Initiatives
Marketwire - Wed Mar 19, 7:43AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces it has hired marketing and branding specialists to support the firms brand and online marketing awareness, as well as provide an update on its medical marijuana initiatives.
CannabisFN Weekly: Cannabis Initiatives Gain Steam throughout U.S.
ACCESSWIRE - Mon Mar 17, 8:38AM CDT
Whitefish, MT / March 14, 2014 / Cannabis stocks moved lower last week alongside the overall market, despite significant progress in many political and policy initiatives, as investors locked in profits. The market has been growing increasingly concerned about a slowdown in China after its bearish industrial production readings while the escalating conflict in Ukraine has raised geopolitical risk levels. Investors responded by reducing market exposure to limit risk.
Cannabis Market Continues Rapid Growth: Advancer with Recent Acquisitions Moves Forward to Become Full Reporting Company
PR Newswire - Wed Mar 12, 8:05AM CDT
The Medical Marijuana and Cannabis Industries forge ahead with indications of reaching a point of public acceptance as TV & radio ads are getting more air time. The bustling industry shows no signs of slowing down as the following companies continue to forge on with lessening restrictions: The CannaBusiness Group, Inc. (OTC: CBGI), Cannabis Science, Inc. (OTC: CBIS), GW Pharmaceuticals plc (NASDAQ: GWPH), MediSwipe, Inc. (OTC: MWIP) and Easton Pharmaceuticals Inc. (OTC: EAPH)
Easton Pharmaceuticals Nears Its $1,000,000 Finance Limit for Year, Moves Towards SEC Filing to Receive up to $5,000,000 in Financing; Closes on Medical Marijuana Agreement
Marketwire - Tue Mar 11, 10:54AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces it nearing its limit on financing under regulation offerings. The company is now moving towards a Reg A filing to raise an amount up to $5,000,000 per year from an accredited investor on a best efforts basis. In other events, Easton has closed on an agreement for Medical Marijuana.
Easton Pharmaceuticals Announces Upgrade to Its Proposal With Vodis Innovative Pharmaceuticals, Signs Additional LOI and Partnership Agreement Towards Medical Marijuana Acquisition(s), Places Funds in Escrow Towards a Final Agreement and Closing
Marketwire - Mon Mar 03, 7:02AM CST
Easton Pharmaceuticals Inc. (OTC: EAPH) a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces it has revised its offer to Vodis Innovative Pharmaceuticals in the companies quest to close on an acceptable agreement towards its medical marijuana initiatives. Additionally, Easton has signed a Letter of Intent with a private Ontario Canada based company presently producing organic medical marijuana, as well as executing an additional letter of intent towards a partnership agreement for the purchase of various marijuana producing companies who have all filed applications with health Canada for medical marijuana distribution and growing licenses under the MMPR (Medical Marijuana For Medical Purposes Regulations) which includes a revenue producing acquisition.
Easton Pharmaceuticals Announces the Launching of Hempstral SA, a New Hemp Based Anti Ageing Product & Reaches Marketing Develop and Distribution Agreement With HempLifeToday.com
Marketwire - Thu Feb 27, 7:52AM CST
Easton Pharmaceuticals Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces its has designed and launched its new Hemp based product, Hempstral SA, and has reached an agreement with Hemp Life Today, LLC, a wholly owned subsidiary of Global Links Corp. Hemp Life Today will assist in developing a marketing and distribution program as well as both companies jointly developing a new line of innovative Hemp based products to be marketed on the HempLifeToday.com website, for US and global distribution.
Easton Pharmaceuticals to Attend and Introduce Its New & Existing Product Line at the Total Health Show
Marketwire - Thu Feb 20, 7:39AM CST
Easton Pharmaceuticals Inc. (OTC: EAPH) a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces it will attend and present at the Total Health Show to be held on April 4,5 and 6 in Toronto, Canada.
Easton Pharmaceuticals Is in Receipt of Proposal to Increase Current Financing; Provides Other Initiative Updates
Marketwire - Mon Feb 10, 8:15AM CST
Easton Pharmaceuticals Inc. (OTC: EAPH) a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces it has received a proposal from an accredited investor to increase its financing from the current $1,000,000 per year it is eligible to currently receive and has been receiving, to $5,000,000 per year by filing a Regulation A Offering Statement with the SEC.
Easton Pharmaceutical, Inc. Analyst Report and Medical Marijuana Initiatives - by BrokerBank Securities, Inc.
PR Newswire - Mon Feb 10, 6:00AM CST
Easton Pharmaceutical, Inc. (PINKSHEETS: EAPH) is a company that owns, designs, develops, and markets topically-delivered drugs and therapeutic / cosmetic healthcare products. Easton Pharmaceuticals product "VIORRA", is an over-the-counter aid for the treatment to restore and improve vaginal moisture and elasticity which is believed to have a positive effect on women's sexual desire and arousal, FSAD (Female Sexual Arousal Disorder). The world market demand for this female condition is conservatively estimated to be in excess of $2 billion. VIORRA is a topical, daily-use product classified by the FDA as containing Generally Recognized Safe ingredients.
Easton Pharmaceuticals Signs Letter of Intent / NDA, Enters Into Negotiations With Private B.C. Company Who Has Received Federal License Approval on Medical Marijuana & Closes on Agreement to Engage Leading Legal Consultant
Marketwire - Fri Feb 07, 8:17AM CST
Easton Pharmaceuticals Inc. (OTC: EAPH) a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces It has finalized and closed on agreement to engage a leading legal consultant on medical marijuana. Subsequent to this agreement, Easton has signed a Letter Of Intent / NDA and has entered into high level negotiations with a private company based out of British Columbia who has been approved for a medical marijuana license to grow and distribute medical marijuana throughout all of Canada.
Easton Pharmaceuticals Announces Update to VIORRA Initiative: Manufacturing Set to Begin
Marketwire - Mon Feb 03, 8:32AM CST
Easton Pharmaceuticals (OTC: EAPH) and its Consultants in Mexico, BMV Medica S.A., announce they have advanced a timetable towards a VIORRA product launch in Mexico, Latin America and potentially the US, Canada and other international markets.
TrendingWallStreet.com Releases Begins Analysis on EAPH, PHOT, CMG, and MAT
ACCESSWIRE - Sun Feb 02, 11:38PM CST
Whether it's a bull or bear market, TrendingWallStreet has you covered. Take a few minutes to register with us at http://www.trendingwallstreet.com/ to get exclusive access to our free stock reports.
Easton Pharmaceuticals Moves Towards Formerly Engaging Leading Legal Expert on Medical Marijuana Licence, as Well as Moving to Next Level of Medical Marijuana Negotiations With Request for Term-Sheet and Final Due Diligence Documents
Marketwire - Wed Jan 29, 7:02AM CST
Easton Pharmaceuticals Inc. (OTC: EAPH) a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces It has moved to the next level of medical marijuana negotiations towards a possible investment / partnership with a private Canadian Company. In addition, Easton Pharmaceuticals is moving towards signing a contract to retain and hire a senior legal expert on Medical Marijuana in Canada to file a growers / distributorship license on behalf of Easton Pharmaceuticals.
Easton Pharmaceuticals Announces Update on Negotiations Towards Its Medical Marijuana Initiatives
Marketwire - Thu Jan 16, 7:52AM CST
Easton Pharmaceuticals Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic healthcare products, today announces an update to its previously announced Medical Marijuana initiatives.
Easton Pharmaceuticals Announces Mr. Kent Deuters as Chief Operations Officer and Special Advisor on the Company's Medical Marijuana Initiatives and Other Company Business Segments; Provides Further Updates on Its Medical Marijuana Program
Marketwire - Thu Apr 03, 11:05AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) announces the appointment of Mr. Kent A. Deuters to the position of Chief Operations Officer and Special Advisor.
CannabisFN Weekly: Cannabis Sector Gears Up for Canada's MMPR
ACCESSWIRE - Mon Mar 31, 8:01AM CDT
Whitefish, MT / March 31, 2014 / The Marijuana Indexâ?¢ moved lower over the past week due in large part to a 40% drop in shares of Cannavest Corp. (OTCBB: CANV) along with broader declines across the sector. Many traders appeared to be locking in profits after a volatile start to 2014 although cannabis stocks showed signs of recovery during Friday's session and long-term industry catalysts like regulatory reform remain very intact.
Easton Pharmaceuticals Announces Changes in Management and New Additions to Advisory Board; Appoints Dr. Albert PhD as New Marketing and Technology Officer and Appoints Tim Zorn, Current CEO of HempLifeToday.com to Advisory Board
Marketwire - Mon Mar 31, 7:03AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) -- announces it has appointed Carla Pepe as its new CEO and President, replacing John Adams who will assume the position of CFO. The company also announces the addition of Dr. Lilla Albert PhD to the advisory board, chief marketing officer, and Mr. Tim Zorn, current CEO of HempLifeToday.com (OTC: GLCO) to advisory board.
Easton Pharmaceuticals Announces Signing LOI for Joint Venture Towards Private Medical Marijuana Colorado Grower and Licenses; Provides Clarification on Its Canadian Medical Marijuana Initiatives
Marketwire - Fri Mar 28, 9:45AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces it has signed a letter of intent for the creation of a possible JV with another US company towards a Private Medical Marijuana company in the state of Colorado.
Easton Pharmaceuticals Announces Update to Its Cancer Drug Initiative: Majority Acquisition, Patent Strategy and Clinical Development Along With New Partnership Proposal Involving Medicinal Marijuana Drug Development
Marketwire - Tue Mar 25, 7:46AM CDT
Easton Pharmaceuticals, Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, announces it has entered into an agreement towards securing majority control of the cancer drug Xilive, pending certain conditions and a new partnership proposal towards medicinal marijuana.
Cannabis Science Finalizes $1 Million in New Financing
ACCESSWIRE - Wed Mar 19, 10:22AM CDT
A developer of cannabis-based pharmaceutical products Cannabis Science Inc. (NASDAQ OTC: CBIS) announced that it has finalized its $1,000,000 private placement and the funds have already been put into the bank.
Easton Pharmaceuticals Announces It Has Engaged Online Marketing and Branding Specialists to Support the Firm's Updated Products, Branding and Website Launch; Provides Update on Its Medical Marijuana Initiatives
Marketwire - Wed Mar 19, 7:43AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces it has hired marketing and branding specialists to support the firms brand and online marketing awareness, as well as provide an update on its medical marijuana initiatives.
CannabisFN Weekly: Cannabis Initiatives Gain Steam throughout U.S.
ACCESSWIRE - Mon Mar 17, 8:38AM CDT
Whitefish, MT / March 14, 2014 / Cannabis stocks moved lower last week alongside the overall market, despite significant progress in many political and policy initiatives, as investors locked in profits. The market has been growing increasingly concerned about a slowdown in China after its bearish industrial production readings while the escalating conflict in Ukraine has raised geopolitical risk levels. Investors responded by reducing market exposure to limit risk.
Cannabis Market Continues Rapid Growth: Advancer with Recent Acquisitions Moves Forward to Become Full Reporting Company
PR Newswire - Wed Mar 12, 8:05AM CDT
The Medical Marijuana and Cannabis Industries forge ahead with indications of reaching a point of public acceptance as TV & radio ads are getting more air time. The bustling industry shows no signs of slowing down as the following companies continue to forge on with lessening restrictions: The CannaBusiness Group, Inc. (OTC: CBGI), Cannabis Science, Inc. (OTC: CBIS), GW Pharmaceuticals plc (NASDAQ: GWPH), MediSwipe, Inc. (OTC: MWIP) and Easton Pharmaceuticals Inc. (OTC: EAPH)
Easton Pharmaceuticals Nears Its $1,000,000 Finance Limit for Year, Moves Towards SEC Filing to Receive up to $5,000,000 in Financing; Closes on Medical Marijuana Agreement
Marketwire - Tue Mar 11, 10:54AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces it nearing its limit on financing under regulation offerings. The company is now moving towards a Reg A filing to raise an amount up to $5,000,000 per year from an accredited investor on a best efforts basis. In other events, Easton has closed on an agreement for Medical Marijuana.
Easton Pharmaceuticals Announces Upgrade to Its Proposal With Vodis Innovative Pharmaceuticals, Signs Additional LOI and Partnership Agreement Towards Medical Marijuana Acquisition(s), Places Funds in Escrow Towards a Final Agreement and Closing
Marketwire - Mon Mar 03, 7:02AM CST
Easton Pharmaceuticals Inc. (OTC: EAPH) a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces it has revised its offer to Vodis Innovative Pharmaceuticals in the companies quest to close on an acceptable agreement towards its medical marijuana initiatives. Additionally, Easton has signed a Letter of Intent with a private Ontario Canada based company presently producing organic medical marijuana, as well as executing an additional letter of intent towards a partnership agreement for the purchase of various marijuana producing companies who have all filed applications with health Canada for medical marijuana distribution and growing licenses under the MMPR (Medical Marijuana For Medical Purposes Regulations) which includes a revenue producing acquisition.
Easton Pharmaceuticals Announces the Launching of Hempstral SA, a New Hemp Based Anti Ageing Product & Reaches Marketing Develop and Distribution Agreement With HempLifeToday.com
Marketwire - Thu Feb 27, 7:52AM CST
Easton Pharmaceuticals Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces its has designed and launched its new Hemp based product, Hempstral SA, and has reached an agreement with Hemp Life Today, LLC, a wholly owned subsidiary of Global Links Corp. Hemp Life Today will assist in developing a marketing and distribution program as well as both companies jointly developing a new line of innovative Hemp based products to be marketed on the HempLifeToday.com website, for US and global distribution.
Easton Pharmaceuticals to Attend and Introduce Its New & Existing Product Line at the Total Health Show
Marketwire - Thu Feb 20, 7:39AM CST
Easton Pharmaceuticals Inc. (OTC: EAPH) a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces it will attend and present at the Total Health Show to be held on April 4,5 and 6 in Toronto, Canada.
Easton Pharmaceuticals Is in Receipt of Proposal to Increase Current Financing; Provides Other Initiative Updates
Marketwire - Mon Feb 10, 8:15AM CST
Easton Pharmaceuticals Inc. (OTC: EAPH) a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces it has received a proposal from an accredited investor to increase its financing from the current $1,000,000 per year it is eligible to currently receive and has been receiving, to $5,000,000 per year by filing a Regulation A Offering Statement with the SEC.
Easton Pharmaceutical, Inc. Analyst Report and Medical Marijuana Initiatives - by BrokerBank Securities, Inc.
PR Newswire - Mon Feb 10, 6:00AM CST
Easton Pharmaceutical, Inc. (PINKSHEETS: EAPH) is a company that owns, designs, develops, and markets topically-delivered drugs and therapeutic / cosmetic healthcare products. Easton Pharmaceuticals product "VIORRA", is an over-the-counter aid for the treatment to restore and improve vaginal moisture and elasticity which is believed to have a positive effect on women's sexual desire and arousal, FSAD (Female Sexual Arousal Disorder). The world market demand for this female condition is conservatively estimated to be in excess of $2 billion. VIORRA is a topical, daily-use product classified by the FDA as containing Generally Recognized Safe ingredients.
Easton Pharmaceuticals Signs Letter of Intent / NDA, Enters Into Negotiations With Private B.C. Company Who Has Received Federal License Approval on Medical Marijuana & Closes on Agreement to Engage Leading Legal Consultant
Marketwire - Fri Feb 07, 8:17AM CST
Easton Pharmaceuticals Inc. (OTC: EAPH) a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces It has finalized and closed on agreement to engage a leading legal consultant on medical marijuana. Subsequent to this agreement, Easton has signed a Letter Of Intent / NDA and has entered into high level negotiations with a private company based out of British Columbia who has been approved for a medical marijuana license to grow and distribute medical marijuana throughout all of Canada.
Easton Pharmaceuticals Announces Update to VIORRA Initiative: Manufacturing Set to Begin
Marketwire - Mon Feb 03, 8:32AM CST
Easton Pharmaceuticals (OTC: EAPH) and its Consultants in Mexico, BMV Medica S.A., announce they have advanced a timetable towards a VIORRA product launch in Mexico, Latin America and potentially the US, Canada and other international markets.
TrendingWallStreet.com Releases Begins Analysis on EAPH, PHOT, CMG, and MAT
ACCESSWIRE - Sun Feb 02, 11:38PM CST
Whether it's a bull or bear market, TrendingWallStreet has you covered. Take a few minutes to register with us at http://www.trendingwallstreet.com/ to get exclusive access to our free stock reports.
Easton Pharmaceuticals Moves Towards Formerly Engaging Leading Legal Expert on Medical Marijuana Licence, as Well as Moving to Next Level of Medical Marijuana Negotiations With Request for Term-Sheet and Final Due Diligence Documents
Marketwire - Wed Jan 29, 7:02AM CST
Easton Pharmaceuticals Inc. (OTC: EAPH) a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces It has moved to the next level of medical marijuana negotiations towards a possible investment / partnership with a private Canadian Company. In addition, Easton Pharmaceuticals is moving towards signing a contract to retain and hire a senior legal expert on Medical Marijuana in Canada to file a growers / distributorship license on behalf of Easton Pharmaceuticals.
Easton Pharmaceuticals Announces Update on Negotiations Towards Its Medical Marijuana Initiatives
Marketwire - Thu Jan 16, 7:52AM CST
Easton Pharmaceuticals Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic healthcare products, today announces an update to its previously announced Medical Marijuana initiatives.
